Combination COVID booster targeting Omicron approved in U.K.


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
The United Kingdom is now the first country to authorize a COVID-19 booster shot that targets both the highly-infectious Omicron variant as well as the original virus strain from early in the pandemic, CNN reports Monday.
The so-called "bivalent" shot, which is an updated version of the one made by Moderna, was approved for adults by the Medicines and Healthcare products Regulatory Agency "after it was found to meet the U.K. regulator's standards of safety, quality and effectiveness," said an official government release. "No serious safety concerns were identified."
The MHRA described any side effects of the bivalent shot to be the same as the original Moderna booster, as well as "typically mild and self-resolving." The U.K.'s Joint Committee on Vaccination and Immunisation will ultimately advise on rollout and eligibility, CNN notes, though CNBC reports the booster is expected to become available in the fall.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The first generation of COVID-19 vaccines being used in the U.K. continue to provide important protection against the disease and save lives," said MHRA Chief Executive Dr. June Raine. "What this bivalent vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve."
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Brigid is a staff writer at The Week and a graduate of Syracuse University's S.I. Newhouse School of Public Communications. Her passions include improv comedy, David Fincher films, and breakfast food. She lives in New York.
-
You can now get a new Covid booster shot. Should you?
Unless you are old or otherwise at high risk, it isn't a 'slam dunk'
By Peter Weber Published
-
FDA to re-evaluate effectiveness of common nasal congestion ingredient
Speed Read
By Justin Klawans Published
-
A flesh-eating bacteria is growing in numbers due to climate change
Speed Read
By Devika Rao Published
-
CDC recommends new RSV vaccine for infants under 8 months
Speed Read
By Devika Rao Published
-
U.S. health agency advises easing federal marijuana restrictions
Speed Read
By Peter Weber Published
-
Medicare drug price negotiations start with 1st 10 drugs, pharmaceutical industry lawsuits
Speed Read
By Peter Weber Published
-